These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6439914)

  • 1. [A case of primary macroglobulinemia responded to actinomycin D and aclacinomycin A].
    Toyokawa Y; Yoshida Y; Uchiyama T; Kanoh T; Uchino H; Ito K; Kasakura S; Sotobayashi H; Osamura Y; Mizuno Y
    Rinsho Ketsueki; 1984 Aug; 25(8):1239-43. PubMed ID: 6439914
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.
    Warrell RP; Kempin SJ
    Am J Clin Oncol; 1983 Feb; 6(1):81-4. PubMed ID: 6573124
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aclarubicin in metastatic thyroid cancer: initial clinical experience].
    Langsteger W; Lind P; Eber O; Költringer P; Klima G
    Radiobiol Radiother (Berl); 1988; 29(2):243-5. PubMed ID: 3165198
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
    Mathé G; Gil MA; Delgado M; Bayssas M; Gouveia J; Ribaud P; Machover D; Misset JL; de Vassal F; Schwarzenberg L; Jasmin C; Hayat M
    Recent Results Cancer Res; 1980; 74():217-22. PubMed ID: 6893752
    [No Abstract]   [Full Text] [Related]  

  • 5. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
    Kish JA; Al-Sarraf M
    Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aclacinomycin A.
    Oka S; Mathé G; Mitrou PS
    Cancer Treat Rev; 1984 Dec; 11(4):299-302. PubMed ID: 6598408
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Gockerman JP; Silberman H; Bartolucci AA
    Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II evaluation of aclacinomycin-A (NSC-208734) in adenocarcinoma of the kidney.
    Decker DA; Drelichman A; Opipari MI; Al-Sarraf M
    Am J Clin Oncol; 1984 Oct; 7(5):527-8. PubMed ID: 6594927
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase II study of aclacinomycin A in acute leukemia in adults.
    Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
    Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma.
    Martino S; Decker DA; Hynes HE; Kresge CL
    Invest New Drugs; 1987 Dec; 5(4):373-4. PubMed ID: 3481362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of aclacinomycin-A in head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2335-41. PubMed ID: 6594077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aclarubicin: a new drug in cancer treatment. Proceedings of a satellite symposium. June 17th, 1985, Stockholm.
    Eur J Haematol Suppl; 1987; 47():1-76. PubMed ID: 3471522
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of new antileukemic agents].
    Yamada K; Ohno R
    Nihon Rinsho; 1981 Aug; 39(8):2815-20. PubMed ID: 7038206
    [No Abstract]   [Full Text] [Related]  

  • 16. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
    Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
    Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
    [No Abstract]   [Full Text] [Related]  

  • 19. Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.
    Evensen SA; Wisløff F; Müller E; Talstad I; Waage A; Johansen L
    Eur J Haematol Suppl; 1987; 47():43-7. PubMed ID: 3471524
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
    Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Benavides M; Lotz JP; Misset JL; de Vassal F; Tapiero H
    Eur J Haematol Suppl; 1987; 47():33-42. PubMed ID: 3471523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.